Skip to main content

Done Deal, 3233 Eglinton Ave., No. 1301, Toronto

3233 EGLINTON AVE., No. 1301, TORONTO

ASKING PRICE $278,800

SELLING PRICE $332,000

Story continues below advertisement

PREVIOUS SELLING PRICE $222,500 (2015); $204,000 (2011); $171,000 (2007)

TAXES $1,376 (2016)

DAYS ON THE MARKET Seven

LISTING AGENT Sohail Mansoor, Royal LePage Signature Realty

The Action: Normally, it takes a long time to sell condo units in older buildings, but with a citywide lack of listings on the market, the timeline to sell this two-bedroom-plus-solarium suite in an early-1990s building was dramatically shortened. Listed in early February, offers were held back for one week, at which point the seller deliberated over 11 bids.

"What we've seen in the market over the past six months is that the condo market has seen new life and increase in demand," agent Sohail Mansoor said. "There hadn't been a sale over $300,000 in the building ever, so we raised the bar there."

What They Got: In the east tower of the Guildwood Terrace community, this more-than-1,100 square-foot suite has a traditional layout with the kitchen separated from open living and dining areas along the windows. Natural light bathes the solarium and a balcony off one bedroom. The unit has two bathrooms, ensuite laundry and a kitchen outfitted with stainless-steel appliances. A storage locker and parking are included. Monthly fees of $842 cover utilities, concierge and recreational facilities.

Story continues below advertisement

The Agent's Take: "It's a well-built building that's established and it has extensive amenities, including a pool, squash court, outdoor terrace and tennis court," Mr. Mansoor said. "Plus, it's uncommon in newer buildings to get 1,100 square feet [such as this] for around the $300,000 price point."

Within four hours of listing this property, an offer was placed on this King Street West neighbourhood condo
Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter